Register
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!

 

Clinical Trials
Overview Trusted Sites
Resources Find Support Support Groups News & Events News Feeds
Events Clinical Trials Open Studies Publications Editorial Articles
Research Articles
Review Articles Participate Share your experience
CLOSE

Medical Disclaimer

The medical information on this site is provided as an information resource only, and is not to be used or relied on for any diagnostic or treatment purposes. This information is not intended to be patient education, does not create any patient-physician relationship, and should not be used as a substitute for professional diagnosis and treatment.

Cavernous angioma

Cavernous hemangiomaCerebral cavernous malformation (CCM)Cavernoma
Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 1-6 of 6 results.
Pattern and Management of Intracranial Cavernoma
Status: Not yet recruiting
Last Changed: Nov 28, 2019
First Received: Nov 28, 2019
Disease(s): Management of Intracranial Cavernous Hemangioma
Intervention(s): surgical excision of intracranial cavernoma
CASH (Cavernous Angiomas With Symptomatic Hemorrhage) Trial Readiness
Status: Recruiting
Last Changed: Sep 27, 2019
First Received: Aug 29, 2018
Disease(s): CCM, Cavernoma, Cerebral Cavernous Malformation, Cerebral Cavernous Malformations 1, Cerebral Cavernous Malformations 2, Cerebral Cavernous Malformations 3, Cavernous Angioma
Locations: The University of Chicago Medical Center, Chicago, Illinois, United States
Atorvastatin Treatment of Cavernous Angiomas With Symptomatic Hemorrhage Exploratory Proof of Concept (AT CASH EPOC) Trial
Status: Recruiting
Last Changed: Oct 04, 2018
First Received: Nov 11, 2015
Disease(s): Cerebral Cavernous Malformation
Intervention(s): Atorvastatin, Placebo
Locations: University of Chicago, Chicago, Illinois, United States
Modifiers of Disease Severity in Cerebral Cavernous Malformations
Status: Recruiting
Last Changed: Dec 12, 2019
First Received: Jan 09, 2013
Disease(s): Cavernous Angioma, Familial, Cerebral Cavernous Malformations, Cerebral Cavernous Hemangioma
Locations: Barrow Neurological Institute, Phoenix, Arizona, United States
University of California, San Francisco, San Francisco, California, United States
University of Chicago, Medicine and Biological Sciences, Chicago, Illinois, United States
Boston Children's Hospital, Boston, Massachusetts, United States
University of New Mexico Health Sciences Center, Albuquerque, New Mexico, United States
... and 3 other locations.
Quantitative Susceptibility Biomarker and Brain Structural Property for Cerebral Cavernous Malformation Related Epilepsy
Status: Recruiting
Last Changed: Sep 04, 2019
First Received: Sep 02, 2019
Disease(s): Cavernous Malformation, Cerebral, Cavernous Angioma, Cavernous Hemangioma, Cavernous Hemangioma of Brain, Seizures, Seizures, Epileptic, Epilepsy
Locations: Beijing Tiantan Hospital, Capital Medical University, Beijing, Beijing, China
Peking University International Hospital, Beijing, Beijing, China
Treatments and Outcomes of Untreated Cerebral Cavernous Malformations in CHina.
Status: Recruiting
Last Changed: Mar 19, 2018
First Received: Mar 16, 2018
Disease(s): Cerebral Cavernous Malformations
Intervention(s): Surgery, Observation
Locations: The first affiliated hospital of fujian medical university, Fuzhou, Fujian, China